ClinicalTrials.gg
Not yet recruitingNCT07942597D-QUITUpdated Nov 17, 2026

An AI-Powered Chatbot Targeting Nicotine and Cannabis Dual Vaping Cessation in Young Adults

An interventional study of D-QUIT App and Questionnaires in Nicotine E-Cigarette Use, Vaping and Vaping Cessation, sponsored by University of California, San Francisco. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 29 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 29 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 17 studies in Vaping by University of California, San Francisco — 4 open to participants now, 4 under way, none of them phase 3. Vaping · University of California, San Francisco.

Planned enrollment
5th of 17
50 · median 27
Started
2027
the only one that year
No phase
13 of 17
2 open now
Registered
17th of 17
by date

Among the 17 studies in Vaping by University of California, San Francisco, this one is the 5th largest by planned enrollment, is the only one that started in 2027, is one of 13 with no phase, and was the 17th registered.

Vaping

403 studies on the registry are indexed under Vaping; 96 are open to participants now.

Browse Vaping studies →

Open to participants now

4 of the 17 studies in Vaping by University of California, San Francisco are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 4 open studies →

Where they have run

Who these studies take

Of the 64 Vaping studies recruiting now, 32 (50%) set no upper age limit and 31 (48%) stop at 75 or younger; 13 take children under 18; 40 take healthy volunteers.

This study: 18 Years to 29 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 17 studies in Vaping by University of California, San Francisco, or all of them as a file.
02

Study summary

A pilot study evaluates the feasibility and acceptability of D-QUIT, an AI-powered smartphone app providing personalized behavioral support for nicotine and cannabis vaping cessation among young adults.

Read the detailed description

Primary Objective:

I. To evaluate the feasibility and acceptability of D-QUIT, a smartphone app enhanced by an AI chatbot for vaping cessation.

Secondary Objective:

I. To assess intervention engagement and preliminary vaping cessation outcomes.

03

Conditions studied

  • Nicotine E-Cigarette Use
  • Vaping
  • Vaping Cessation
  • Cessation, Smoking
  • Cannabis Smoking

Keywords

  • AI chatbot
  • Smartphone application
  • Artificial intelligence
  • Young Adults
  • Personalized behavioral support
04

Who can participate

Ages eligible
18 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Speak English.
  2. Ages 18-29.
  3. Live in California.
  4. Own a smartphone.
  5. Report vaping nicotine frequently (20+ days during the past month).
  6. Report vaping cannabis at least weekly.
  7. Intent to quit vaping nicotine in the next 30 days.

Exclusion criteria

Exclusion Criteria:

  1. Younger than 18 years or older than 29 years of age.
  2. unable to read, speak, or understand English.
  3. Unwilling or unable to participate or give .
  4. Do not own a smartphone.
  5. have not vaped nicotine at least 20 days in the past month.
  6. Have not vaped cannabis at least weekly.
  7. Not thinking about quitting vaping within the next 30 days.
  8. Do not live in California.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    D-QUIT Pilot Intervention

    Participants will use the D-QUIT smartphone app for 6 weeks to support their goals for quitting or reducing nicotine and cannabis vaping. During the 2 weeks before their nicotine vaping quit date, participants will receive app notifications to help identify vaping patterns and triggers, set goals, and learn coping skills. Beginning on the quit date, participants will receive tailored messages for 4 weeks with tips for managing withdrawal and support based on their vaping goals. Participants will also be encouraged to interact with the chatbot for 5-15 minutes daily and complete brief morning and end-of-day check-ins about vaping, cravings, mood, and withdrawal symptoms. At the end of the intervention, participants will complete a survey, and a subset will be invited to an interview to provide feedback on D-QUIT.

    Behavioral: D-QUIT App · Other: Questionnaires

Interventions

  • BehavioralD-QUIT App

    A Smartphone App Enhanced by AI Chatbot Delivered Remotely via Mobile Phone

  • OtherQuestionnaires

    Feasibility and Acceptability Measures administered at the end of 6-week intervention.

06

What researchers measure

Primary outcomes

  1. Feasibility of the D-QUIT Smartphone App

    Feasibility will be assessed using the 4-item Feasibility of Intervention Measure (FIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater perceived feasibility of the intervention. Descriptive data will be reported.

    Time frame: At Week 6

  2. Acceptability of the D-QUIT Smartphone App

    Acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM). Each item is rated on a 5-point scale from 1 (Completely disagree) to 5 (Completely agree). Higher item scores indicate greater acceptability of the intervention. Descriptive data will be reported.

    Time frame: At Week 6

Secondary outcomes

  1. Intervention Engagement

    Intervention engagement will be assessed using participants' duration of D-QUIT use (0-6 weeks) and the frequency of chatbot use during the intervention. Descriptive data will be reported.

    Time frame: At Week 6

  2. Preliminary Vaping-Cessation Outcomes

    Preliminary vaping-cessation outcomes will be assessed using self-reported measures of nicotine and cannabis vaping, including the number of days vaped in the past 30 days or the number of quit attempts since starting D-QUIT. Use of other nicotine/tobacco and cannabis products will also be assessed. Descriptive data will be reported.

    Time frame: At Week 6

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Jul 2028, 18 months later.

Of 184 non-industry interventional studies with no phase under Vaping, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 18 months is close to that.

Counting every sponsor, half of 208 studies reached it within 18 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 10, 2026
First posted
Nov 17, 2026
StartEst.
Jan 15, 2027
Primary completionEst.
Jul 31, 2028
CompletionEst.
Jul 31, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942597
Collaborators
Tobacco Related Disease Research Program
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jan 15, 2027 (estimated)
Primary completion
Jul 31, 2028 (estimated)
Completion
Jul 31, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Nhung Nguyen, PhD PharmD
Contact
VapingStudy@ucsf.edu
877-827-3222
Nhung Nguyen, PhD PharmD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion